nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbachol—PLA2G4A—Epirubicin—ovarian cancer	0.745	1	CbGbCtD
Carbachol—CHRM3—muscle of abdomen—ovarian cancer	0.0152	0.343	CbGeAlD
Carbachol—Venous thrombosis—Carboplatin—ovarian cancer	0.0106	0.0614	CcSEcCtD
Carbachol—Fluid overload—Carboplatin—ovarian cancer	0.00917	0.0533	CcSEcCtD
Carbachol—Extravasation—Carboplatin—ovarian cancer	0.00653	0.038	CcSEcCtD
Carbachol—Phlebitis—Carboplatin—ovarian cancer	0.0048	0.0279	CcSEcCtD
Carbachol—PLA2G4A—myometrium—ovarian cancer	0.00383	0.0868	CbGeAlD
Carbachol—Extravasation—Topotecan—ovarian cancer	0.00299	0.0174	CcSEcCtD
Carbachol—PLA2G4A—uterine cervix—ovarian cancer	0.00298	0.0675	CbGeAlD
Carbachol—Extravasation—Melphalan—ovarian cancer	0.00293	0.017	CcSEcCtD
Carbachol—Necrosis—Vinorelbine—ovarian cancer	0.00285	0.0166	CcSEcCtD
Carbachol—PLA2G4A—decidua—ovarian cancer	0.00284	0.0643	CbGeAlD
Carbachol—Venous thrombosis—Paclitaxel—ovarian cancer	0.00278	0.0162	CcSEcCtD
Carbachol—Ulcer—Melphalan—ovarian cancer	0.0027	0.0157	CcSEcCtD
Carbachol—PLA2G4A—endometrium—ovarian cancer	0.00269	0.0611	CbGeAlD
Carbachol—Extravasation—Vinorelbine—ovarian cancer	0.00256	0.0149	CcSEcCtD
Carbachol—PLA2G4A—female reproductive system—ovarian cancer	0.00223	0.0506	CbGeAlD
Carbachol—PLA2G4A—bone marrow—ovarian cancer	0.00211	0.0478	CbGeAlD
Carbachol—PLA2G4A—female gonad—ovarian cancer	0.00203	0.046	CbGeAlD
Carbachol—Infection—Carboplatin—ovarian cancer	0.00202	0.0118	CcSEcCtD
Carbachol—PLA2G4A—vagina—ovarian cancer	0.00202	0.0457	CbGeAlD
Carbachol—Dizziness—Altretamine—ovarian cancer	0.00195	0.0113	CcSEcCtD
Carbachol—Necrosis—Paclitaxel—ovarian cancer	0.00191	0.0111	CcSEcCtD
Carbachol—Phlebitis—Vinorelbine—ovarian cancer	0.00188	0.0109	CcSEcCtD
Carbachol—Vomiting—Altretamine—ovarian cancer	0.00187	0.0109	CcSEcCtD
Carbachol—Hyponatraemia—Melphalan—ovarian cancer	0.00186	0.0108	CcSEcCtD
Carbachol—PLA2G4A—testis—ovarian cancer	0.0018	0.0408	CbGeAlD
Carbachol—Eye irritation—Paclitaxel—ovarian cancer	0.00176	0.0102	CcSEcCtD
Carbachol—Nausea—Altretamine—ovarian cancer	0.00175	0.0102	CcSEcCtD
Carbachol—Pain—Carboplatin—ovarian cancer	0.00174	0.0101	CcSEcCtD
Carbachol—Tenderness—Paclitaxel—ovarian cancer	0.00172	0.01	CcSEcCtD
Carbachol—Extravasation—Paclitaxel—ovarian cancer	0.00172	0.01	CcSEcCtD
Carbachol—Cramp muscle—Topotecan—ovarian cancer	0.00171	0.00993	CcSEcCtD
Carbachol—Hyponatraemia—Vinorelbine—ovarian cancer	0.00163	0.00947	CcSEcCtD
Carbachol—Necrosis—Docetaxel—ovarian cancer	0.00162	0.00944	CcSEcCtD
Carbachol—Body temperature increased—Carboplatin—ovarian cancer	0.00161	0.00935	CcSEcCtD
Carbachol—Venous thrombosis—Epirubicin—ovarian cancer	0.00159	0.00925	CcSEcCtD
Carbachol—CHRM1—female reproductive system—ovarian cancer	0.0015	0.0339	CbGeAlD
Carbachol—Eye irritation—Docetaxel—ovarian cancer	0.00149	0.00867	CcSEcCtD
Carbachol—Venous thrombosis—Doxorubicin—ovarian cancer	0.00147	0.00856	CcSEcCtD
Carbachol—Extravasation—Docetaxel—ovarian cancer	0.00146	0.00849	CcSEcCtD
Carbachol—Sweating—Topotecan—ovarian cancer	0.0014	0.00814	CcSEcCtD
Carbachol—CHRM3—female reproductive system—ovarian cancer	0.00134	0.0304	CbGeAlD
Carbachol—PLA2G4A—lymph node—ovarian cancer	0.00131	0.0296	CbGeAlD
Carbachol—Phlebitis—Paclitaxel—ovarian cancer	0.00127	0.00736	CcSEcCtD
Carbachol—CHRM3—female gonad—ovarian cancer	0.00122	0.0276	CbGeAlD
Carbachol—Flushing—Melphalan—ovarian cancer	0.00119	0.00693	CcSEcCtD
Carbachol—Arrhythmia—Melphalan—ovarian cancer	0.00115	0.00667	CcSEcCtD
Carbachol—Muscle spasms—Topotecan—ovarian cancer	0.0011	0.00638	CcSEcCtD
Carbachol—Hyponatraemia—Paclitaxel—ovarian cancer	0.00109	0.00637	CcSEcCtD
Carbachol—Necrosis—Epirubicin—ovarian cancer	0.00109	0.00636	CcSEcCtD
Carbachol—Abscess—Epirubicin—ovarian cancer	0.00109	0.00631	CcSEcCtD
Carbachol—CHRM3—testis—ovarian cancer	0.00108	0.0245	CbGeAlD
Carbachol—Phlebitis—Docetaxel—ovarian cancer	0.00107	0.00624	CcSEcCtD
Carbachol—Stinging—Epirubicin—ovarian cancer	0.00106	0.00617	CcSEcCtD
Carbachol—Flushing—Vinorelbine—ovarian cancer	0.00104	0.00605	CcSEcCtD
Carbachol—Infection—Chlorambucil—ovarian cancer	0.00104	0.00605	CcSEcCtD
Carbachol—Necrosis—Doxorubicin—ovarian cancer	0.00101	0.00589	CcSEcCtD
Carbachol—Abscess—Doxorubicin—ovarian cancer	0.001	0.00584	CcSEcCtD
Carbachol—Arrhythmia—Vinorelbine—ovarian cancer	0.001	0.00583	CcSEcCtD
Carbachol—Extravasation—Epirubicin—ovarian cancer	0.000984	0.00573	CcSEcCtD
Carbachol—Cramp muscle—Paclitaxel—ovarian cancer	0.000982	0.00571	CcSEcCtD
Carbachol—Stinging—Doxorubicin—ovarian cancer	0.000981	0.00571	CcSEcCtD
Carbachol—Hyponatraemia—Docetaxel—ovarian cancer	0.000928	0.0054	CcSEcCtD
Carbachol—Infection—Topotecan—ovarian cancer	0.000925	0.00538	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Docetaxel—ovarian cancer	0.000924	0.00538	CcSEcCtD
Carbachol—Dyspepsia—Chlorambucil—ovarian cancer	0.000921	0.00536	CcSEcCtD
Carbachol—Sweating increased—Paclitaxel—ovarian cancer	0.000918	0.00534	CcSEcCtD
Carbachol—Extravasation—Doxorubicin—ovarian cancer	0.000911	0.0053	CcSEcCtD
Carbachol—Ulcer—Epirubicin—ovarian cancer	0.000908	0.00528	CcSEcCtD
Carbachol—Infection—Melphalan—ovarian cancer	0.000906	0.00527	CcSEcCtD
Carbachol—Hyperhidrosis—Topotecan—ovarian cancer	0.0009	0.00524	CcSEcCtD
Carbachol—Pain—Chlorambucil—ovarian cancer	0.000895	0.0052	CcSEcCtD
Carbachol—Hypotension—Melphalan—ovarian cancer	0.000852	0.00496	CcSEcCtD
Carbachol—Hyperkalaemia—Epirubicin—ovarian cancer	0.000844	0.00491	CcSEcCtD
Carbachol—Ulcer—Doxorubicin—ovarian cancer	0.00084	0.00489	CcSEcCtD
Carbachol—Salivary hypersecretion—Epirubicin—ovarian cancer	0.000834	0.00485	CcSEcCtD
Carbachol—Cramp muscle—Docetaxel—ovarian cancer	0.000832	0.00484	CcSEcCtD
Carbachol—Body temperature increased—Chlorambucil—ovarian cancer	0.000827	0.00481	CcSEcCtD
Carbachol—Abdominal pain—Chlorambucil—ovarian cancer	0.000827	0.00481	CcSEcCtD
Carbachol—Dyspepsia—Topotecan—ovarian cancer	0.00082	0.00477	CcSEcCtD
Carbachol—Dyspepsia—Melphalan—ovarian cancer	0.000803	0.00467	CcSEcCtD
Carbachol—Pain—Topotecan—ovarian cancer	0.000796	0.00463	CcSEcCtD
Carbachol—Infection—Vinorelbine—ovarian cancer	0.000791	0.0046	CcSEcCtD
Carbachol—Hyperkalaemia—Doxorubicin—ovarian cancer	0.000781	0.00454	CcSEcCtD
Carbachol—Pain—Melphalan—ovarian cancer	0.00078	0.00454	CcSEcCtD
Carbachol—Salivary hypersecretion—Doxorubicin—ovarian cancer	0.000772	0.00449	CcSEcCtD
Carbachol—Hypotension—Vinorelbine—ovarian cancer	0.000744	0.00433	CcSEcCtD
Carbachol—Abdominal pain—Topotecan—ovarian cancer	0.000736	0.00428	CcSEcCtD
Carbachol—Body temperature increased—Topotecan—ovarian cancer	0.000736	0.00428	CcSEcCtD
Carbachol—Phlebitis—Epirubicin—ovarian cancer	0.000724	0.00421	CcSEcCtD
Carbachol—Diarrhoea—Chlorambucil—ovarian cancer	0.000716	0.00416	CcSEcCtD
Carbachol—Flushing—Paclitaxel—ovarian cancer	0.0007	0.00407	CcSEcCtD
Carbachol—Pain—Vinorelbine—ovarian cancer	0.000681	0.00396	CcSEcCtD
Carbachol—Arrhythmia—Paclitaxel—ovarian cancer	0.000674	0.00392	CcSEcCtD
Carbachol—Phlebitis—Doxorubicin—ovarian cancer	0.000669	0.00389	CcSEcCtD
Carbachol—Vomiting—Chlorambucil—ovarian cancer	0.000665	0.00387	CcSEcCtD
Carbachol—Flatulence—Paclitaxel—ovarian cancer	0.000647	0.00376	CcSEcCtD
Carbachol—Diarrhoea—Topotecan—ovarian cancer	0.000637	0.00371	CcSEcCtD
Carbachol—Muscle spasms—Paclitaxel—ovarian cancer	0.000631	0.00367	CcSEcCtD
Carbachol—Abdominal pain—Vinorelbine—ovarian cancer	0.00063	0.00366	CcSEcCtD
Carbachol—Body temperature increased—Vinorelbine—ovarian cancer	0.00063	0.00366	CcSEcCtD
Carbachol—Hyponatraemia—Epirubicin—ovarian cancer	0.000626	0.00364	CcSEcCtD
Carbachol—Diarrhoea—Melphalan—ovarian cancer	0.000624	0.00363	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Epirubicin—ovarian cancer	0.000623	0.00363	CcSEcCtD
Carbachol—Nausea—Chlorambucil—ovarian cancer	0.000621	0.00361	CcSEcCtD
Carbachol—Dizziness—Topotecan—ovarian cancer	0.000616	0.00358	CcSEcCtD
Carbachol—Flushing—Docetaxel—ovarian cancer	0.000593	0.00345	CcSEcCtD
Carbachol—Vomiting—Topotecan—ovarian cancer	0.000592	0.00344	CcSEcCtD
Carbachol—Syncope—Paclitaxel—ovarian cancer	0.000589	0.00343	CcSEcCtD
Carbachol—Rash—Topotecan—ovarian cancer	0.000587	0.00342	CcSEcCtD
Carbachol—Dermatitis—Topotecan—ovarian cancer	0.000587	0.00341	CcSEcCtD
Carbachol—Headache—Topotecan—ovarian cancer	0.000583	0.00339	CcSEcCtD
Carbachol—Vomiting—Melphalan—ovarian cancer	0.00058	0.00337	CcSEcCtD
Carbachol—Hyponatraemia—Doxorubicin—ovarian cancer	0.000579	0.00337	CcSEcCtD
Carbachol—Loss of consciousness—Paclitaxel—ovarian cancer	0.000577	0.00336	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	0.000577	0.00336	CcSEcCtD
Carbachol—Rash—Melphalan—ovarian cancer	0.000575	0.00334	CcSEcCtD
Carbachol—Dermatitis—Melphalan—ovarian cancer	0.000574	0.00334	CcSEcCtD
Carbachol—Arrhythmia—Docetaxel—ovarian cancer	0.000571	0.00332	CcSEcCtD
Carbachol—Nausea—Topotecan—ovarian cancer	0.000553	0.00322	CcSEcCtD
Carbachol—Diarrhoea—Vinorelbine—ovarian cancer	0.000545	0.00317	CcSEcCtD
Carbachol—Nausea—Melphalan—ovarian cancer	0.000542	0.00315	CcSEcCtD
Carbachol—Asthma—Epirubicin—ovarian cancer	0.000539	0.00313	CcSEcCtD
Carbachol—Muscle spasms—Docetaxel—ovarian cancer	0.000535	0.00311	CcSEcCtD
Carbachol—Infection—Paclitaxel—ovarian cancer	0.000532	0.0031	CcSEcCtD
Carbachol—Shock—Paclitaxel—ovarian cancer	0.000527	0.00307	CcSEcCtD
Carbachol—Dizziness—Vinorelbine—ovarian cancer	0.000527	0.00306	CcSEcCtD
Carbachol—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000518	0.00301	CcSEcCtD
Carbachol—Vomiting—Vinorelbine—ovarian cancer	0.000507	0.00295	CcSEcCtD
Carbachol—Rash—Vinorelbine—ovarian cancer	0.000502	0.00292	CcSEcCtD
Carbachol—Dermatitis—Vinorelbine—ovarian cancer	0.000502	0.00292	CcSEcCtD
Carbachol—Hypotension—Paclitaxel—ovarian cancer	0.000501	0.00291	CcSEcCtD
Carbachol—Headache—Vinorelbine—ovarian cancer	0.000499	0.0029	CcSEcCtD
Carbachol—Syncope—Docetaxel—ovarian cancer	0.000499	0.0029	CcSEcCtD
Carbachol—Asthma—Doxorubicin—ovarian cancer	0.000498	0.0029	CcSEcCtD
Carbachol—Loss of consciousness—Docetaxel—ovarian cancer	0.000489	0.00285	CcSEcCtD
Carbachol—Nausea—Vinorelbine—ovarian cancer	0.000473	0.00275	CcSEcCtD
Carbachol—Dyspepsia—Paclitaxel—ovarian cancer	0.000472	0.00274	CcSEcCtD
Carbachol—Sweating—Epirubicin—ovarian cancer	0.000461	0.00268	CcSEcCtD
Carbachol—Pain—Paclitaxel—ovarian cancer	0.000458	0.00267	CcSEcCtD
Carbachol—Infection—Docetaxel—ovarian cancer	0.000451	0.00263	CcSEcCtD
Carbachol—Shock—Docetaxel—ovarian cancer	0.000447	0.0026	CcSEcCtD
Carbachol—Sweating—Doxorubicin—ovarian cancer	0.000426	0.00248	CcSEcCtD
Carbachol—Hypotension—Docetaxel—ovarian cancer	0.000424	0.00247	CcSEcCtD
Carbachol—Abdominal pain—Paclitaxel—ovarian cancer	0.000424	0.00246	CcSEcCtD
Carbachol—Body temperature increased—Paclitaxel—ovarian cancer	0.000424	0.00246	CcSEcCtD
Carbachol—Flushing—Epirubicin—ovarian cancer	0.0004	0.00233	CcSEcCtD
Carbachol—Dyspepsia—Docetaxel—ovarian cancer	0.0004	0.00233	CcSEcCtD
Carbachol—Pain—Docetaxel—ovarian cancer	0.000388	0.00226	CcSEcCtD
Carbachol—Arrhythmia—Epirubicin—ovarian cancer	0.000385	0.00224	CcSEcCtD
Carbachol—Flushing—Doxorubicin—ovarian cancer	0.00037	0.00215	CcSEcCtD
Carbachol—Flatulence—Epirubicin—ovarian cancer	0.00037	0.00215	CcSEcCtD
Carbachol—Diarrhoea—Paclitaxel—ovarian cancer	0.000367	0.00213	CcSEcCtD
Carbachol—Muscle spasms—Epirubicin—ovarian cancer	0.000361	0.0021	CcSEcCtD
Carbachol—Abdominal pain—Docetaxel—ovarian cancer	0.000359	0.00209	CcSEcCtD
Carbachol—Body temperature increased—Docetaxel—ovarian cancer	0.000359	0.00209	CcSEcCtD
Carbachol—Arrhythmia—Doxorubicin—ovarian cancer	0.000356	0.00207	CcSEcCtD
Carbachol—Dizziness—Paclitaxel—ovarian cancer	0.000354	0.00206	CcSEcCtD
Carbachol—Flatulence—Doxorubicin—ovarian cancer	0.000342	0.00199	CcSEcCtD
Carbachol—Vomiting—Paclitaxel—ovarian cancer	0.000341	0.00198	CcSEcCtD
Carbachol—Rash—Paclitaxel—ovarian cancer	0.000338	0.00197	CcSEcCtD
Carbachol—Dermatitis—Paclitaxel—ovarian cancer	0.000338	0.00196	CcSEcCtD
Carbachol—Syncope—Epirubicin—ovarian cancer	0.000337	0.00196	CcSEcCtD
Carbachol—Headache—Paclitaxel—ovarian cancer	0.000336	0.00195	CcSEcCtD
Carbachol—Muscle spasms—Doxorubicin—ovarian cancer	0.000334	0.00194	CcSEcCtD
Carbachol—Loss of consciousness—Epirubicin—ovarian cancer	0.00033	0.00192	CcSEcCtD
Carbachol—Nausea—Paclitaxel—ovarian cancer	0.000318	0.00185	CcSEcCtD
Carbachol—Syncope—Doxorubicin—ovarian cancer	0.000311	0.00181	CcSEcCtD
Carbachol—Diarrhoea—Docetaxel—ovarian cancer	0.000311	0.00181	CcSEcCtD
Carbachol—Loss of consciousness—Doxorubicin—ovarian cancer	0.000305	0.00178	CcSEcCtD
Carbachol—Infection—Epirubicin—ovarian cancer	0.000304	0.00177	CcSEcCtD
Carbachol—Shock—Epirubicin—ovarian cancer	0.000301	0.00175	CcSEcCtD
Carbachol—Dizziness—Docetaxel—ovarian cancer	0.0003	0.00175	CcSEcCtD
Carbachol—Hyperhidrosis—Epirubicin—ovarian cancer	0.000296	0.00172	CcSEcCtD
Carbachol—Vomiting—Docetaxel—ovarian cancer	0.000289	0.00168	CcSEcCtD
Carbachol—Rash—Docetaxel—ovarian cancer	0.000286	0.00167	CcSEcCtD
Carbachol—Hypotension—Epirubicin—ovarian cancer	0.000286	0.00167	CcSEcCtD
Carbachol—Dermatitis—Docetaxel—ovarian cancer	0.000286	0.00166	CcSEcCtD
Carbachol—Headache—Docetaxel—ovarian cancer	0.000285	0.00166	CcSEcCtD
Carbachol—Infection—Doxorubicin—ovarian cancer	0.000282	0.00164	CcSEcCtD
Carbachol—Shock—Doxorubicin—ovarian cancer	0.000279	0.00162	CcSEcCtD
Carbachol—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000274	0.00159	CcSEcCtD
Carbachol—Nausea—Docetaxel—ovarian cancer	0.00027	0.00157	CcSEcCtD
Carbachol—Dyspepsia—Epirubicin—ovarian cancer	0.00027	0.00157	CcSEcCtD
Carbachol—Hypotension—Doxorubicin—ovarian cancer	0.000265	0.00154	CcSEcCtD
Carbachol—Pain—Epirubicin—ovarian cancer	0.000262	0.00152	CcSEcCtD
Carbachol—Dyspepsia—Doxorubicin—ovarian cancer	0.00025	0.00145	CcSEcCtD
Carbachol—Pain—Doxorubicin—ovarian cancer	0.000242	0.00141	CcSEcCtD
Carbachol—Abdominal pain—Epirubicin—ovarian cancer	0.000242	0.00141	CcSEcCtD
Carbachol—Body temperature increased—Epirubicin—ovarian cancer	0.000242	0.00141	CcSEcCtD
Carbachol—Body temperature increased—Doxorubicin—ovarian cancer	0.000224	0.0013	CcSEcCtD
Carbachol—Abdominal pain—Doxorubicin—ovarian cancer	0.000224	0.0013	CcSEcCtD
Carbachol—Diarrhoea—Epirubicin—ovarian cancer	0.00021	0.00122	CcSEcCtD
Carbachol—Dizziness—Epirubicin—ovarian cancer	0.000203	0.00118	CcSEcCtD
Carbachol—Vomiting—Epirubicin—ovarian cancer	0.000195	0.00113	CcSEcCtD
Carbachol—Diarrhoea—Doxorubicin—ovarian cancer	0.000194	0.00113	CcSEcCtD
Carbachol—Rash—Epirubicin—ovarian cancer	0.000193	0.00112	CcSEcCtD
Carbachol—Dermatitis—Epirubicin—ovarian cancer	0.000193	0.00112	CcSEcCtD
Carbachol—Headache—Epirubicin—ovarian cancer	0.000192	0.00112	CcSEcCtD
Carbachol—Dizziness—Doxorubicin—ovarian cancer	0.000187	0.00109	CcSEcCtD
Carbachol—Nausea—Epirubicin—ovarian cancer	0.000182	0.00106	CcSEcCtD
Carbachol—Vomiting—Doxorubicin—ovarian cancer	0.00018	0.00105	CcSEcCtD
Carbachol—Rash—Doxorubicin—ovarian cancer	0.000179	0.00104	CcSEcCtD
Carbachol—Dermatitis—Doxorubicin—ovarian cancer	0.000179	0.00104	CcSEcCtD
Carbachol—Headache—Doxorubicin—ovarian cancer	0.000178	0.00103	CcSEcCtD
Carbachol—Nausea—Doxorubicin—ovarian cancer	0.000168	0.00098	CcSEcCtD
Carbachol—CHRM2—GPCR ligand binding—CXCL8—ovarian cancer	2.56e-05	0.000658	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—PIK3CA—ovarian cancer	2.45e-05	0.000629	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—YAP1—ovarian cancer	2.43e-05	0.000623	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—YAP1—ovarian cancer	2.42e-05	0.000621	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—YAP1—ovarian cancer	2.39e-05	0.000615	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—XIAP—ovarian cancer	2.38e-05	0.00061	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—TP53—ovarian cancer	2.37e-05	0.000609	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—XIAP—ovarian cancer	2.37e-05	0.000608	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—FASN—ovarian cancer	2.36e-05	0.000605	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—XIAP—ovarian cancer	2.35e-05	0.000602	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—CAV1—ovarian cancer	2.34e-05	0.0006	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—SLC5A5—ovarian cancer	2.32e-05	0.000595	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—SMARCA4—ovarian cancer	2.32e-05	0.000595	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—SMARCA4—ovarian cancer	2.31e-05	0.000593	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—PIK3CB—ovarian cancer	2.31e-05	0.000592	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—SMARCA4—ovarian cancer	2.29e-05	0.000587	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—HRAS—ovarian cancer	2.27e-05	0.000582	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—EREG—ovarian cancer	2.26e-05	0.00058	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—EREG—ovarian cancer	2.25e-05	0.000578	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—SLC2A1—ovarian cancer	2.24e-05	0.000575	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.23e-05	0.000573	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—EREG—ovarian cancer	2.23e-05	0.000573	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—CXCL8—ovarian cancer	2.22e-05	0.000569	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—CYP1B1—ovarian cancer	2.15e-05	0.000551	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—PIK3CG—ovarian cancer	2.13e-05	0.000546	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—IL2—ovarian cancer	2.12e-05	0.000544	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PGR—ovarian cancer	2.12e-05	0.000544	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—TERT—ovarian cancer	2.11e-05	0.000542	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PGR—ovarian cancer	2.11e-05	0.000542	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PGR—ovarian cancer	2.09e-05	0.000537	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—AKT1—ovarian cancer	2e-05	0.000514	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—PIK3CG—ovarian cancer	1.99e-05	0.000512	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—PIK3CG—ovarian cancer	1.99e-05	0.00051	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PARP1—ovarian cancer	1.97e-05	0.000506	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—PIK3CG—ovarian cancer	1.97e-05	0.000505	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PARP1—ovarian cancer	1.96e-05	0.000504	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CAV1—ovarian cancer	1.95e-05	0.000501	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PARP1—ovarian cancer	1.94e-05	0.000499	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PPP2R1A—ovarian cancer	1.9e-05	0.000489	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—IL6ST—ovarian cancer	1.88e-05	0.000484	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—ESR1—ovarian cancer	1.88e-05	0.000483	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—IL6ST—ovarian cancer	1.88e-05	0.000482	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—PIK3CD—ovarian cancer	1.87e-05	0.00048	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—IL6ST—ovarian cancer	1.86e-05	0.000477	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—IL6ST—ovarian cancer	1.85e-05	0.000475	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—PIK3CG—ovarian cancer	1.81e-05	0.000465	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—PIK3CG—ovarian cancer	1.8e-05	0.000463	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—PIK3CG—ovarian cancer	1.79e-05	0.000459	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—APC—ovarian cancer	1.78e-05	0.000457	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PIK3CG—ovarian cancer	1.78e-05	0.000457	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—NRAS—ovarian cancer	1.78e-05	0.000457	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—ABCB1—ovarian cancer	1.77e-05	0.000454	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—PIK3CD—ovarian cancer	1.75e-05	0.00045	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—PIK3CD—ovarian cancer	1.75e-05	0.000448	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—TYMS—ovarian cancer	1.74e-05	0.000446	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—PIK3CD—ovarian cancer	1.73e-05	0.000444	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—MAPK3—ovarian cancer	1.7e-05	0.000437	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—PIK3CB—ovarian cancer	1.63e-05	0.000419	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—MAPK1—ovarian cancer	1.62e-05	0.000416	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—EGFR—ovarian cancer	1.62e-05	0.000416	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PPP2R1A—ovarian cancer	1.6e-05	0.00041	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PPP2R1A—ovarian cancer	1.59e-05	0.000409	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—PIK3CD—ovarian cancer	1.59e-05	0.000408	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—PIK3CD—ovarian cancer	1.59e-05	0.000407	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PPP2R1A—ovarian cancer	1.58e-05	0.000405	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—PIK3CD—ovarian cancer	1.57e-05	0.000403	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PIK3CD—ovarian cancer	1.56e-05	0.000401	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—KRAS—ovarian cancer	1.53e-05	0.000393	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—PIK3CB—ovarian cancer	1.53e-05	0.000392	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—PIK3CB—ovarian cancer	1.52e-05	0.000391	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—PIK3CB—ovarian cancer	1.51e-05	0.000387	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—CXCL8—ovarian cancer	1.47e-05	0.000377	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—CXCL8—ovarian cancer	1.46e-05	0.000376	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—CXCL8—ovarian cancer	1.45e-05	0.000372	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—PTEN—ovarian cancer	1.41e-05	0.000362	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—PIK3CA—ovarian cancer	1.41e-05	0.000361	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—IL2—ovarian cancer	1.4e-05	0.00036	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—CAV1—ovarian cancer	1.4e-05	0.000359	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—IL2—ovarian cancer	1.4e-05	0.000359	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—PIK3CB—ovarian cancer	1.39e-05	0.000356	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—IL2—ovarian cancer	1.38e-05	0.000355	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—PIK3CB—ovarian cancer	1.38e-05	0.000355	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—ERBB2—ovarian cancer	1.38e-05	0.000355	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—PIK3CB—ovarian cancer	1.37e-05	0.000351	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MTOR—ovarian cancer	1.36e-05	0.00035	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PIK3CB—ovarian cancer	1.36e-05	0.00035	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—CXCL8—ovarian cancer	1.33e-05	0.000342	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—CXCL8—ovarian cancer	1.33e-05	0.000341	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—CXCL8—ovarian cancer	1.32e-05	0.000338	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CXCL8—ovarian cancer	1.31e-05	0.000336	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—HRAS—ovarian cancer	1.3e-05	0.000334	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CDKN1B—ovarian cancer	1.28e-05	0.000328	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PIK3CG—ovarian cancer	1.27e-05	0.000327	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—IL2—ovarian cancer	1.27e-05	0.000327	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—IL2—ovarian cancer	1.27e-05	0.000326	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—TERT—ovarian cancer	1.27e-05	0.000326	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TERT—ovarian cancer	1.26e-05	0.000325	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—IL2—ovarian cancer	1.26e-05	0.000323	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CASP3—ovarian cancer	1.25e-05	0.000322	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TERT—ovarian cancer	1.25e-05	0.000322	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—IL2—ovarian cancer	1.25e-05	0.000321	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—IL6—ovarian cancer	1.25e-05	0.00032	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CCND1—ovarian cancer	1.22e-05	0.000313	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CTNNB1—ovarian cancer	1.21e-05	0.00031	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MMP9—ovarian cancer	1.18e-05	0.000304	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PTEN—ovarian cancer	1.18e-05	0.000302	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CAV1—ovarian cancer	1.17e-05	0.000301	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CAV1—ovarian cancer	1.17e-05	0.0003	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CAV1—ovarian cancer	1.16e-05	0.000297	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—AKT1—ovarian cancer	1.15e-05	0.000295	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—ESR1—ovarian cancer	1.13e-05	0.00029	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—ESR1—ovarian cancer	1.13e-05	0.000289	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PIK3CD—ovarian cancer	1.12e-05	0.000288	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—ESR1—ovarian cancer	1.12e-05	0.000287	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IL6ST—ovarian cancer	1.11e-05	0.000286	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IL6ST—ovarian cancer	1.11e-05	0.000285	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IL6ST—ovarian cancer	1.1e-05	0.000282	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PIK3CG—ovarian cancer	1.07e-05	0.000274	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—APC—ovarian cancer	1.07e-05	0.000274	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—NRAS—ovarian cancer	1.07e-05	0.000274	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—APC—ovarian cancer	1.07e-05	0.000274	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PIK3CG—ovarian cancer	1.07e-05	0.000274	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—NRAS—ovarian cancer	1.07e-05	0.000274	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—VEGFA—ovarian cancer	1.06e-05	0.000273	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PIK3CG—ovarian cancer	1.06e-05	0.000271	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—APC—ovarian cancer	1.06e-05	0.000271	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—NRAS—ovarian cancer	1.06e-05	0.000271	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—STAT3—ovarian cancer	1.05e-05	0.00027	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—NRAS—ovarian cancer	1.05e-05	0.00027	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—MAPK3—ovarian cancer	1.02e-05	0.000263	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—MAPK3—ovarian cancer	1.02e-05	0.000262	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—MAPK3—ovarian cancer	1.01e-05	0.000259	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MAPK3—ovarian cancer	1.01e-05	0.000258	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—PIK3CA—ovarian cancer	9.94e-06	0.000255	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MYC—ovarian cancer	9.79e-06	0.000251	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PIK3CB—ovarian cancer	9.76e-06	0.000251	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—MAPK1—ovarian cancer	9.74e-06	0.00025	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—EGFR—ovarian cancer	9.74e-06	0.00025	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—MAPK1—ovarian cancer	9.71e-06	0.000249	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—EGFR—ovarian cancer	9.71e-06	0.000249	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—MAPK1—ovarian cancer	9.61e-06	0.000247	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—EGFR—ovarian cancer	9.61e-06	0.000247	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MAPK1—ovarian cancer	9.57e-06	0.000246	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—EGFR—ovarian cancer	9.57e-06	0.000246	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PIK3CD—ovarian cancer	9.4e-06	0.000241	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PIK3CD—ovarian cancer	9.37e-06	0.000241	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—PIK3CA—ovarian cancer	9.31e-06	0.000239	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—PIK3CA—ovarian cancer	9.28e-06	0.000238	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PIK3CD—ovarian cancer	9.28e-06	0.000238	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—KRAS—ovarian cancer	9.2e-06	0.000236	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—PIK3CA—ovarian cancer	9.19e-06	0.000236	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—KRAS—ovarian cancer	9.17e-06	0.000235	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—KRAS—ovarian cancer	9.08e-06	0.000233	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—KRAS—ovarian cancer	9.04e-06	0.000232	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—PIK3CA—ovarian cancer	8.45e-06	0.000217	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PTEN—ovarian cancer	8.44e-06	0.000217	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—PIK3CA—ovarian cancer	8.43e-06	0.000216	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—PIK3CA—ovarian cancer	8.34e-06	0.000214	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PIK3CA—ovarian cancer	8.31e-06	0.000213	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—ERBB2—ovarian cancer	8.3e-06	0.000213	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—ERBB2—ovarian cancer	8.27e-06	0.000212	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—ERBB2—ovarian cancer	8.19e-06	0.00021	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MTOR—ovarian cancer	8.19e-06	0.00021	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PIK3CB—ovarian cancer	8.19e-06	0.00021	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PIK3CB—ovarian cancer	8.16e-06	0.00021	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MTOR—ovarian cancer	8.16e-06	0.00021	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—AKT1—ovarian cancer	8.12e-06	0.000208	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MTOR—ovarian cancer	8.08e-06	0.000208	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PIK3CB—ovarian cancer	8.08e-06	0.000208	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—TP53—ovarian cancer	8.04e-06	0.000206	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CXCL8—ovarian cancer	7.87e-06	0.000202	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CXCL8—ovarian cancer	7.85e-06	0.000201	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—HRAS—ovarian cancer	7.82e-06	0.000201	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—HRAS—ovarian cancer	7.79e-06	0.0002	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CXCL8—ovarian cancer	7.77e-06	0.0002	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—HRAS—ovarian cancer	7.72e-06	0.000198	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—HRAS—ovarian cancer	7.69e-06	0.000197	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CDKN1B—ovarian cancer	7.69e-06	0.000197	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CDKN1B—ovarian cancer	7.66e-06	0.000197	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—AKT1—ovarian cancer	7.6e-06	0.000195	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CDKN1B—ovarian cancer	7.59e-06	0.000195	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—AKT1—ovarian cancer	7.58e-06	0.000195	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CASP3—ovarian cancer	7.53e-06	0.000193	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IL2—ovarian cancer	7.52e-06	0.000193	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CASP3—ovarian cancer	7.51e-06	0.000193	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—AKT1—ovarian cancer	7.51e-06	0.000193	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IL2—ovarian cancer	7.5e-06	0.000193	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—IL6—ovarian cancer	7.48e-06	0.000192	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—IL6—ovarian cancer	7.46e-06	0.000192	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CASP3—ovarian cancer	7.44e-06	0.000191	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IL2—ovarian cancer	7.43e-06	0.000191	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—IL6—ovarian cancer	7.39e-06	0.00019	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—IL6—ovarian cancer	7.36e-06	0.000189	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CCND1—ovarian cancer	7.33e-06	0.000188	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CCND1—ovarian cancer	7.31e-06	0.000188	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CTNNB1—ovarian cancer	7.26e-06	0.000186	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CCND1—ovarian cancer	7.24e-06	0.000186	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CTNNB1—ovarian cancer	7.24e-06	0.000186	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CTNNB1—ovarian cancer	7.17e-06	0.000184	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MMP9—ovarian cancer	7.12e-06	0.000183	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MMP9—ovarian cancer	7.1e-06	0.000182	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PTEN—ovarian cancer	7.08e-06	0.000182	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PTEN—ovarian cancer	7.05e-06	0.000181	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MMP9—ovarian cancer	7.03e-06	0.00018	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PTEN—ovarian cancer	6.99e-06	0.000179	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—AKT1—ovarian cancer	6.9e-06	0.000177	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—AKT1—ovarian cancer	6.88e-06	0.000177	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—AKT1—ovarian cancer	6.82e-06	0.000175	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—AKT1—ovarian cancer	6.79e-06	0.000174	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—VEGFA—ovarian cancer	6.39e-06	0.000164	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—VEGFA—ovarian cancer	6.37e-06	0.000164	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—STAT3—ovarian cancer	6.33e-06	0.000163	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—NRAS—ovarian cancer	6.31e-06	0.000162	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—VEGFA—ovarian cancer	6.31e-06	0.000162	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—STAT3—ovarian cancer	6.31e-06	0.000162	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—NRAS—ovarian cancer	6.29e-06	0.000162	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—STAT3—ovarian cancer	6.25e-06	0.00016	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—NRAS—ovarian cancer	6.23e-06	0.00016	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MAPK3—ovarian cancer	6.05e-06	0.000155	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MAPK3—ovarian cancer	6.03e-06	0.000155	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MAPK3—ovarian cancer	5.97e-06	0.000153	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PIK3CA—ovarian cancer	5.95e-06	0.000153	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MYC—ovarian cancer	5.88e-06	0.000151	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MYC—ovarian cancer	5.86e-06	0.000151	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MYC—ovarian cancer	5.81e-06	0.000149	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MAPK1—ovarian cancer	5.75e-06	0.000148	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—EGFR—ovarian cancer	5.75e-06	0.000148	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MAPK1—ovarian cancer	5.74e-06	0.000147	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—EGFR—ovarian cancer	5.73e-06	0.000147	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MAPK1—ovarian cancer	5.68e-06	0.000146	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—EGFR—ovarian cancer	5.68e-06	0.000146	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—KRAS—ovarian cancer	5.43e-06	0.00014	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—KRAS—ovarian cancer	5.42e-06	0.000139	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—KRAS—ovarian cancer	5.36e-06	0.000138	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PIK3CA—ovarian cancer	4.99e-06	0.000128	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PIK3CA—ovarian cancer	4.98e-06	0.000128	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PIK3CA—ovarian cancer	4.93e-06	0.000127	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—AKT1—ovarian cancer	4.86e-06	0.000125	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—TP53—ovarian cancer	4.83e-06	0.000124	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TP53—ovarian cancer	4.81e-06	0.000124	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TP53—ovarian cancer	4.77e-06	0.000122	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—HRAS—ovarian cancer	4.62e-06	0.000119	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—HRAS—ovarian cancer	4.6e-06	0.000118	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—HRAS—ovarian cancer	4.56e-06	0.000117	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IL6—ovarian cancer	4.42e-06	0.000114	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IL6—ovarian cancer	4.41e-06	0.000113	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IL6—ovarian cancer	4.36e-06	0.000112	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—AKT1—ovarian cancer	4.08e-06	0.000105	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—AKT1—ovarian cancer	4.07e-06	0.000104	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—AKT1—ovarian cancer	4.03e-06	0.000103	CbGpPWpGaD
